Generation X und Millennials haben höheres Krebsrisiko als vorherige Generationen: Mögliche Ursachen und Implikationen

Zusammenfassung

Krebs tritt bei Erwachsenen zunehmend häufiger bereits vor dem 50. Lebensjahr auf.

In den USA weisen die Generationen X und Y bei einer Reihe von Malignomen nun ein fast doppelt so hohes Erkrankungsrisiko auf wie die Babyboomer im gleichen Lebensalter. Von 1990 bis 2019 hat die Inzidenz der sog. Early-Onset-Malignome (EOM; Malignome, die früh ausbrechen) weltweit um 79,1% zugenommen. Anstiege der Krebsinzidenz bei jüngeren Generationen spiegeln v.a. Veränderungen der Expositionen im ersten Lebensdrittel wider und könnten eine künftig größere Krankheitslast vorhersagen. Einige Ursachen, aber auch mögliche Konsequenzen für die Krebsprävention werden in dieser Übersicht angesprochen.

Abstract

The incidence of early-onset malignancy (EOM) diagnosed under the age of 50 has been increasing worldwide. In the USA, Generation X and the millennials are up to 2 times more likely to develop 17 of the 34 most common cancers than the baby boomers at any given age. Globally, the incidence of EOM increased by 79.1% between 1990 and 2019. Early-life exposure may be linked with EOM development and may forecast a greater disease burden in the future. Possible causes and consequences are discussed with regards to cancer prevention.

Schlüsselwörter

Tumor - Neoplasie - frühes Auftreten - junge Erwachsene - Prävention

Keywords

tumor - neoplasm - early-onset - young adults - prevention

Publication History

Article published online:
04 June 2025

• Literatur

• 1 Zhao J, Xu L, Sun J. et al. Global trends in incidence, death, burden and risk factors of early-onset cancer from 1990 to 2019. BMJ Oncology 2023; 2: e000049
• 2 Sung H, Jiang C, Bandi P. et al. Differences in cancer rates among adults born between 1920 and 1990 in the USA: an analysis of population-based cancer registry data. Lancet Public Health 2024; 9 (08) e583-e593
• 3 Sung H, Siegel RL, Laversanne M. et al. Colorectal cancer incidence trends in younger versus older adults: an analysis of population-based cancer registry data. Lancet Oncol 2024; 11
• 4 Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin 2024; 74 (01) 12-49
• 5 Ugai T, Sasamoto N, Lee HY. et al. Is early-onset cancer an emerging global epidemic? Current evidence and future implications. Nat Rev Clin Oncol 2022; 19 (10) 656-673
• 6 Liu H, Xu Z, Song C. et al. Burden of gastrointestinal cancers among people younger than 50 years in China, 1990 to 2019. Public Health 2024; 234: 112-119
• 7 Li Q, Yu M, Lv H. et al. Burden of early-onset colorectal cancer along with attributable risk factors from 1990 to 2019: a comparative study between China and other G20 countries. BMC Public Health 2023; 23 (01) 1463
• 8 Chen J, Yang W. Comparing cohort and period trends of early-onset colorectal cancer: a global analysis. JNCI Cancer Spectr 2024; 8 (04)
• 9 Wengler A, Rommel A, Plaß D. et al. Verlorene Lebensjahre durch Tod – Eine umfassende Analyse des Sterbegeschehens in Deutschland, durchgeführt im Rahmen des Projekts BURDEN 2020. Dtsch Arztebl Int 2021; 118 (09) 137-144
• 10 Zinkeng A, Taylor FL, Cheong SH. et al. Early Onset Colorectal Cancer: Molecular Underpinnings Accelerating Occurrence. Cell Mol Gastroenterol Hepatol 2024; 101425
• 11 Gandini A, Taieb J, Blons H. et al. Early-Onset colorectal Cancer: From the laboratory to the clinic. Cancer Treat Rev 2024; 130: 102821
• 12 Scherübl H, Herzig S. Krebs als Spätkomplikation von Metabolischem Syndrom, Prädiabetes und Typ-2-Diabetes. In: Deutscher Gesundheitsbericht Diabetes. Wiesbaden: MedTriX GmbH; 2024
• 13 Célind J, Bygdell M, Martikainen J. et al. Childhood overweight and risk of obesity-related adult cancer in men. Cancer Commun (Lond) 2022; 42 (06) 576-579
• 14 Liu T, Liu CA, Zhang QS. et al. Association of the age of onset of metabolic syndrome with the risk of all cancer types. Diabetes Metab Syndr 2023; 17 (11) 102896
• 15 Zhang Y, Song M, Cao Y. et al. Incident Early- and Later-Onset Type 2 Diabetes and Risk of Early- and Later-Onset Cancer: Prospective Cohort Study. Diabetes Care 2023; 46 (01) 120-129
• 16 Li Y, Tian J, Hou T. et al. Association Between Age at Diabetes Diagnosis and Subsequent Incidence of Cancer: A Longitudinal Population-Based Cohort. Diabetes Care 2024; 47 (03) 353-361
• 17 Nguyen LH, Liu PH, Zheng X. et al. Sedentary Behaviors, TV Viewing Time, and Risk of Young-Onset Colorectal Cancer. JNCI Cancer Spectr 2018; 2 (04) pky073
• 18 Ellis L, Milne RL, Moore MM. et al. Estimating cancers attributable to physical inactivity in Australia. J Sci Med Sport 2024; 27 (03) 149-153
• 19 Scherübl H. Tabakrauchen und Krebsrisiko. Dtsch Med Wochenschr 2021; 146 (06) 412-417
• 20 Scherübl H. Alkoholkonsum und Krebsrisiko. Dtsch Med Wochenschr 2019; 144 (19) 1354-1360
• 21 Ogino S, Ugai T. The global epidemic of early-onset cancer: Nature, nurture, or both?. Ann Oncol 2024;
• 22 Mishra A, Giuliani G, Longo VD. Nutrition and dietary restrictions in cancer prevention. Biochim Biophys Acta Rev Cancer 2024; 1879 (01) 189063
• 23 Kartal E, Schmidt TSB, Molina-Montes E. et al. A faecal microbiota signature with high specificity for pancreatic cancer. Gut 2022; 71 (07) 1359-1372
• 24 Yang X, An H, He Y. et al. Comprehensive analysis of microbiota signature across 32 cancer types. Front Oncol 2023; 13: 1127225
• 25 Qin Y, Tong X, Mei WJ. et al. Consistent signatures in the human gut microbiome of old- and young-onset colorectal cancer. Nat Commun 2024; 15 (01) 3396
• 26 Yang J, He Q, Lu F. et al. A distinct microbiota signature precedes the clinical diagnosis of hepatocellular carcinoma. Gut Microbes 2023; 15 (01) 2201159
• 27 Le Provost B, Parent MÉ, Villeneuve PJ. et al. Residential exposure to ambient fine particulate matter (PM2.5) and nitrogen dioxide (NO2) and incident breast cancer among young women in Ontario, Canada. Cancer Epidemiol 2024; 92: 102606
• 28 Ou JY, Hanson HA, Ramsay JM. et al. Fine Particulate Matter Air Pollution and Mortality among Pediatric, Adolescent, and Young Adult Cancer Patients. Cancer Epidemiol Biomarkers Prev 2020; 29 (10) 1929-1939
• 29 Murphy CC, Zaki TA. Changing epidemiology of colorectal cancer – birth cohort effects and emerging risk factors. Nat Rev Gastroenterol Hepatol 2024; 21 (01) 25-34
• 30 Vuik FE, Nieuwenburg SA, Bardou M. et al. Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years. Gut 2019; 68 (10) 1820-1826
• 31 Koh B, Tan DJH, Ng CH. et al. Patterns in Cancer Incidence Among People Younger Than 50 Years in the US, 2010 to 2019. JAMA Netw Open 2023; 6 (08) e2328171
• 32 Spaander MCW, Zauber AG, Syngal S. et al. Young-onset colorectal cancer. Nat Rev Dis Primers 2023; 9 (01)
• 33 Wu Y, Li Y, Giovannucci E. Potenzial Impact of Time Trend of Lifestyle Risk Factors on Burden of Major Gastrointestinal Cancers in China. Gastroenterology 2021; 161 (06) 1830-1841
• 34 Li Z, Zhang X, Sun C. et al. Global, regional, and national burdens of early onset pancreatic cancer in adolescents and adults aged 15–49 years from 1990 to 2019 based on the Global Burden of Disease Study 2019: a cross-sectional study. Int J Surg 2024; 110 (04) 1929-1940
• 35 Perrotta G, Abboud Y, Osipov A. et al. Trends in incidence and survival of early-stage pancreatic ductal adenocarcinoma in the United States. JCO 2024; 42 (Suppl. 03) 633-633
• 36 Scherübl H. Prävention des Pankreaskarzinoms. Dtsch Med Wochenschr 2023; 148 (05) 246-252
• 37 Palumbo C, Pecoraro A, Rosiello G. et al. Renal cell carcinoma incidence rates and trends in young adults aged 20–39 years. Cancer Epidemiol 2020; 67: 101762
• 38 Teng Y, Xia C, Li H. et al. Cancer statistics for young adults aged 20 to 49 years in China from 2000 to 2017: a population-based registry study. Sci China Life Sci 2024; 67 (04) 711-719
• 39 Giaquinto AN, Sung H, Newman LA. et al. Breast cancer statistics 2024. CA Cancer J Clin 2024;
• 40 Xu S, Murtagh S, Han Y. et al. Breast Cancer Incidence Among US Women Aged 20 to 49 Years by Race, Stage, and Hormone Receptor Status. JAMA Netw Open 2024; 7 (01) e2353331